Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 8, 2022
Biomarkers of alveolar epithelial injury and endothelial dysfunction are associated with scores of pulmonary edema in invasively ventilated patientsLeila N Atmowihardjo, Nanon F L Heijnen, Marry R Smit, et al.
The Ultrasound Journal|October 2, 2023
The diagnostic accuracy of lung ultrasound to determine PiCCO-derived extravascular lung water in invasively ventilated patients with COVID-19 ARDSLeila N Atmowihardjo, Job R Schippers, Mark E Haaksma, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|May 13, 2026
Diagnostic and management dilemmas in pulmonary hypertensionRobin Condliffe, Jurjan Aman, Athénaïs Boucly, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 4, 2023
Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19Nadia Baalbaki, Erik Duijvelaar, Medhat M Said, et al.
Vascular Pharmacology|April 15, 2015
ROCK2 primes the endothelium for vascular hyperpermeability responses by raising baseline junctional tensionCora M L Beckers, Nebojsa Knezevic, Erik T Valent, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 5, 2021
Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib studyImke H Bartelink, Pierre M Bet, Nicolas Widmer, et al.
Circulation|April 17, 2023
SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary HypertensionRachel Walters, Eleni Vasilaki, Jurjan Aman, et al.
Vascular Pharmacology|September 13, 2015
Globular adiponectin controls insulin-mediated vasoreactivity in muscle through AMPKα2Michiel P de Boer, Rick I Meijer, Erik A Richter, et al.
Trials|February 17, 2022
The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19Leila Atmowihardjo, Job R Schippers, Imke H Bartelink, et al.
Science Advances|December 20, 2024
TNIK: A redox sensor in endothelial cell permeabilityJustin Joachim, Davide Maselli, Emmanouela Petsolari, et al.
Pageof 7